Core Research Group

Milton 4064

0 studies enrolling now · 3 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Studies at this site

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed